Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 3 | Future Journal of Pharmaceutical Sciences

Fig. 3

From: Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway

Fig. 3

Metformin and asarone block HepG2 cells in G0/G1 phase in hyperglycemic condition a Cell cycle profile of HepG2 cells cultured in normal glucose (NG; 5.5 mM), high glucose (HG; 25 mM), HG + Metformin HCl, and HG + Asarone for 16 h and stained with PI-RNase was determined by flow cytometry. b Bar diagrams represent the percentage (%) of cells in different phases of the cell cycle

Back to article page